Dopamine content and synthesis in retina and n. accumbens septi: pharmacological and light-induced modifications.
D012369:2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy- / Q000494:pharmacology; D000221:Adaptation, Ocular; D000375:Aging; D000818:Animals; D001001:Anura; D002415:Cats; D002645:Chickens; D006224:Cricetinae; D003624:Darkness; D004295:Dihydroxyphenylalanine / Q000378:metabolism; D004298:Dopamine / Q000096:biosynthesis / Q000378:metabolism*; D018492:Dopamine Antagonists; D006054:Goldfish; D006168:Guinea Pigs; D066298:In Vitro Techniques; D008027:Light; D051379:Mice; D009830:Olfactory Bulb / Q000378:metabolism*; D011817:Rabbits; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012160:Retina / Q000187:drug effects / Q000378:metabolism*; D013045:Species Specificity
D018492:Dopamine Antagonists; D012369:2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D004298:Dopamine